Max Lafontan
Inserm-U858
institut de médecine moléculaire Rangueil
IFR31-institut Louis-Bugnard
1, avenue Jean-Poulhès
France
Name/email consistency: high
- Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Lafontan, M., Girard, J. Diabetes Metab. (2008)
- Control of lipolysis by natriuretic peptides and cyclic GMP. Lafontan, M., Moro, C., Berlan, M., Crampes, F., Sengenes, C., Galitzky, J. Trends Endocrinol. Metab. (2008)
- Role of adipokines in the control of energy metabolism: focus on adiponectin. Lafontan, M., Viguerie, N. Curr. Opin. Pharmacol (2006)
- Fat cells: afferent and efferent messages define new approaches to treat obesity. Lafontan, M. Annu. Rev. Pharmacol. Toxicol. (2005)
- An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Lafontan, M., Moro, C., Sengenes, C., Galitzky, J., Crampes, F., Berlan, M. Arterioscler. Thromb. Vasc. Biol. (2005)
- Do regional differences in adipocyte biology provide new pathophysiological insights?. Lafontan, M., Berlan, M. Trends Pharmacol. Sci. (2003)